Moderate

Medication-related osteonecrosis of the jaw (MRONJ)

Bisphosphonate/antiresorptive jaw necrosis · Dental & Oral
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Exposed, non-healing jaw bone (>8 weeks) in a patient on antiresorptive (bisphosphonates, denosumab) or antiangiogenic drugs, with no history of head and neck radiotherapy. Often precipitated by dental extraction; higher risk with IV bisphosphonates/denosumab for malignancy.

Red flags

  • Pathological fracture or orocutaneous fistula
  • Spreading infection / systemic sepsis
  • Suspected malignancy
  • Rapid progression of exposed bone

Assessment

Differential diagnosis

  • Osteoradionecrosis
  • Chronic osteomyelitis
  • Metastatic/primary jaw malignancy
  • Dental abscess / alveolar osteitis
  • Periodontal disease
  • Odontogenic infection

Investigations

  • Drug history — bisphosphonates, denosumab, antiangiogenics; route and duration
  • Confirm no prior head/neck radiotherapy
  • Oral exam — exposed/necrotic bone or probeable fistula >8 weeks
  • OPG / CT to assess extent and pathological fracture
  • Exclude metastasis/malignancy
  • Bloods if systemic infection suspected

Management

  • Confirm diagnosis and stage (asymptomatic exposed bone vs infection vs fracture/fistula)
  • Optimise oral hygiene with antiseptic mouthwash
  • Treat secondary infection with antibiotics and analgesia as needed
  • Avoid unnecessary surgery/extractions in affected bone; conservative care for early disease
  • Refer to OMFS for staging and management (sequestrectomy/resection for advanced disease)
  • Liaise with the prescribing team about drug holiday for malignancy indications (individualised)
  • Reinforce prevention: dental assessment and treatment BEFORE starting antiresorptives
  • Safety-net for progression, fracture or spreading infection

Drugs & doses

Chlorhexidine 0.2% mouthwash — 10 mL BD — antiseptic rinse
Amoxicillin — 500 mg PO TDS (+ metronidazole 400 mg PO TDS) — secondary infection
Doxycycline — 100 mg PO OD — penicillin-allergic alternative
Paracetamol +/- opioid — analgesia titrated to pain

Disposition

Refer to OMFS for staging and conservative/surgical management; treat infection and pain; coordinate with the prescribing team and emphasise prevention.

Complications & pitfalls

  • Chronic pain and infection
  • Pathological fracture
  • Fistula formation
  • Extensive bone loss requiring resection
  • Impaired nutrition

Exam pearls

  • Risk is much higher with IV bisphosphonates/denosumab for cancer than oral bisphosphonates for osteoporosis
  • Prevention is paramount — complete invasive dental work before starting antiresorptive therapy
  • Do not stop antiresorptives without discussion with the prescriber; drug holidays are individualised

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.